Close Menu

NEW YORK (GenomeWeb) – Pillar Biosciences announced a strategic partnership and joint venture with China Biotech Services Holdings today that is aimed at the precision diagnostics market in Asia.

Pillar Bio will create a JV with Central Laboratory, a subsidiary of China Biotech Services, to provide precision diagnostic products and services to Hong Kong, Macau, South Korea, and Southeast Asia. Additionally, the JV will distribute Pillar Bio's products, including the SLIMamp and Pivat-based cancer panels, in parts of China.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.